adidas AG (BST:ADS1)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	29,737	42,280	32,882	24,627	48,512	58,100
Market Cap Growth	-11.23%	28.58%	33.52%	-49.23%	-16.50%	2.20%
Enterprise Value	34,782	46,465	38,045	30,179	50,468	62,358
Last Close Price	80.50	118.15	90.67	62.26	124.83	143.26
PE Ratio	24.74	55.34	-	40.24	22.93	134.49
PS Ratio	1.21	1.79	1.54	1.09	2.29	3.15
PB Ratio	5.35	7.21	6.68	4.60	6.19	8.68
P/TBV Ratio	8.33	11.20	11.34	7.46	8.17	13.69
P/FCF Ratio	36.94	16.97	15.04	-	17.98	51.97
P/OCF Ratio	24.26	14.53	12.90	-	15.20	39.10
EV/Sales Ratio	1.42	1.96	1.78	1.34	2.38	3.38
EV/EBITDA Ratio	11.73	25.08	48.46	24.88	20.09	52.31
EV/EBIT Ratio	19.37	35.12	135.87	44.25	25.30	84.15
EV/FCF Ratio	43.21	18.65	17.40	-	18.71	55.78
Debt / Equity Ratio	0.99	0.95	1.13	1.21	0.68	0.88
Debt / EBITDA Ratio	1.85	2.24	4.05	3.39	1.70	3.14
Debt / FCF Ratio	6.80	2.24	2.54	-	1.98	5.27
Asset Turnover	1.25	1.23	1.12	1.06	0.98	0.88
Inventory Turnover	2.44	2.45	2.14	2.38	2.49	2.17
Quick Ratio	0.45	0.59	0.55	0.48	0.77	0.76
Current Ratio	1.25	1.24	1.22	1.27	1.56	1.38
Return on Equity (ROE)	22.95%	15.27%	-1.13%	3.85%	20.54%	6.72%
Return on Assets (ROA)	5.74%	4.28%	0.91%	2.01%	5.77%	2.22%
Return on Capital (ROIC)	9.98%	7.54%	1.57%	3.41%	9.69%	3.79%
Return on Capital Employed (ROCE)	17.00%	12.00%	2.80%	6.20%	15.10%	6.10%
Earnings Yield	4.04%	1.81%	-0.23%	2.48%	4.36%	0.74%
FCF Yield	2.71%	5.89%	6.65%	-3.99%	5.56%	1.92%
Dividend Yield	0.88%	1.69%	0.77%	1.12%	2.64%	2.09%
Payout Ratio	29.70%	16.36%	-	99.67%	27.65%	-
Buyback Yield / Dilution	0.00%	-0.00%	2.57%	5.62%	0.50%	1.24%
Total Shareholder Return	0.88%	1.69%	3.34%	6.74%	3.15%	3.33%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.